Summary
- Current Price
- As of today, SLS price is $11.05, up +0.09% on
- Current Price All-Time High
- SLS price is currently -100.00% below its historical high of $718,500.00 set on
- Market Cap
- SLS current market cap is $2B, up +1305.74% over the past 365 days
- Revenue
- SLS current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for SLS is on
Profile
| Metric | Value |
|---|---|
| Full Name | SELLAS Life Sciences Group, Inc. |
| Ticker | NASDAQ: SLS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sellaslifesciences.com |
| Employees | 15 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $11.05 | |
| Price, 1D Change | +0.09% | |
| $2B | ||
| - | ||
| - | ||
| 1.89 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.25 | ||
| EPS, 1Y Change | +51.19% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:50 | |
| Next Split | N/A | N/A |
| Last Ticker Change | GALE | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.25 | ||
| EPS Estimate | -$0.21 | N/A |
| EPS Est. Change | +14.74% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $11.05 | |
| Price Target | $27.50 | - |
| Price Tgt. Change | +148.87% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.54 | -$0.50 | +5.98% | |
| -$0.26 | -$0.25 | +5.27% | |
| -$0.21 | N/A | +14.74% | |
| -$0.13 | N/A | +49.25% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $53.09M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $11.05 | |
| $5.73 | ||
| $10.90 | ||
| $6.77 | ||
| $10.65 | ||
| -$0.02 | ||
| 1.89 | ||
| $1.08 | ||
| 47.72 | ||
| 83.40% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$0.25 | ||
| $0.00 | ||
| - | ||
| -$28.27M | ||
| - | ||
| -$26.86M | ||
| - | ||
| -$28.27M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 10.72 | ||
| 10.72 | ||
| - | ||
| - | ||
| 169.37 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 20.23 | ||
| -65.68 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $70.87M | ||
| $71.89M | ||
| $78.35M | ||
| $75.21M | ||
| $7.47M | ||
| $7.02M | ||
| $1.00M | ||
| $544.00K | ||
| $2.95M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $26.86M | ||
| $28.27M | ||
| $0.00 | ||
| $12.25M | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$28.39M | ||
| $0.00 | ||
| $86.30M | ||
| $0.00 | ||
| -$28.39M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Maxim Group | → | |
| Maxim Group | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → | |
| Alliance Global Partners | ||
| Cantor Fitzgerald | ||
| Cantor Fitzgerald | ||
| Oppenheimer | ||
| Maxim Group | → | |
| H.C. Wainwright |
Analyst sentiment
Institutional ownership
Screeners with SLS
FAQ
- What is the ticker symbol for SELLAS Life Sciences Group, Inc.?
- The ticker symbol for SELLAS Life Sciences Group, Inc. is NASDAQ:SLS
- Does SELLAS Life Sciences Group, Inc. pay dividends?
- No, SELLAS Life Sciences Group, Inc. does not pay dividends
- What sector is SELLAS Life Sciences Group, Inc. in?
- SELLAS Life Sciences Group, Inc. is in the Healthcare sector
- What industry is SELLAS Life Sciences Group, Inc. in?
- SELLAS Life Sciences Group, Inc. is in the Biotechnology industry
- What country is SELLAS Life Sciences Group, Inc. based in?
- SELLAS Life Sciences Group, Inc. is headquartered in United States
- When did SELLAS Life Sciences Group, Inc. go public?
- SELLAS Life Sciences Group, Inc. initial public offering (IPO) was on March 12, 2008
- Is SELLAS Life Sciences Group, Inc. in the S&P 500?
- No, SELLAS Life Sciences Group, Inc. is not included in the S&P 500 index
- Is SELLAS Life Sciences Group, Inc. in the NASDAQ 100?
- No, SELLAS Life Sciences Group, Inc. is not included in the NASDAQ 100 index
- Is SELLAS Life Sciences Group, Inc. in the Dow Jones?
- No, SELLAS Life Sciences Group, Inc. is not included in the Dow Jones index
- When was SELLAS Life Sciences Group, Inc. last earnings report?
- SELLAS Life Sciences Group, Inc.'s most recent earnings report was on May 12, 2026
- When does SELLAS Life Sciences Group, Inc. report earnings?
- The next expected earnings date for SELLAS Life Sciences Group, Inc. is August 11, 2026
Data Sources & References
- SLS Official Website www.sellaslifesciences.com
- SLS Profile on Yahoo Finance finance.yahoo.com/quote/SLS
- SLS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sls